Arcturus Therapeutics Holdings (ARCT) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$4.4 million.
- Arcturus Therapeutics Holdings' Other Gross PP&E Adjustments rose 2888.43% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year increase of 2888.43%. This contributed to the annual value of -$5.3 million for FY2024, which is 2728.76% up from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Other Gross PP&E Adjustments stood at -$4.4 million for Q3 2025, which was up 2888.43% from -$3.3 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Other Gross PP&E Adjustments registered a high of $6.8 million during Q1 2022, and its lowest value of -$20.7 million during Q2 2022.
- Its 5-year average for Other Gross PP&E Adjustments is -$6.1 million, with a median of -$6.3 million in 2024.
- The largest annual percentage gain for Arcturus Therapeutics Holdings' Other Gross PP&E Adjustments in the last 5 years was 622242.99% (2022), contrasted with its biggest fall of 296500.69% (2022).
- Over the past 5 years, Arcturus Therapeutics Holdings' Other Gross PP&E Adjustments (Quarter) stood at $4.3 million in 2021, then plummeted by 435.13% to -$14.3 million in 2022, then soared by 48.89% to -$7.3 million in 2023, then increased by 27.29% to -$5.3 million in 2024, then increased by 16.56% to -$4.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$4.4 million in Q3 2025, compared to -$3.3 million in Q2 2025 and -$4.3 million in Q1 2025.